Regorafenib is an oral multi-kinase inhibitor approved by the FDA, which can inhibit angiogenic kinases and the mutant oncogenic kinases KIT, RET, and B-RAF41,42 and modulate TAM re-polarization.43 DSF is a drug used for over six decades for preventing alcohol abuse. This evidence concerns the gene RET and alcohol abuse.